US equities
|
NVDA
$135.83
▼-6.95%
ANT
$85.72
▼-11.78%
MU
$605.10
▼-12.36%
AMD
$431.35
▼-11.82%
AAPL
$346.79
▼-0.69%
SPCX
$128.42
▼-7.23%
MSFT
$487.22
▼-2.22%
AMZN
$252.06
▼-2.06%
NVDA
$135.83
▼-6.95%
ANT
$85.72
▼-11.78%
MU
$605.10
▼-12.36%
AMD
$431.35
▼-11.82%
AAPL
$346.79
▼-0.69%
SPCX
$128.42
▼-7.23%
MSFT
$487.22
▼-2.22%
AMZN
$252.06
▼-2.06%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about CYB004
Recent news which mentions CYB004
Cybin Inc. Q3 Earnings: Clinical Advances Amid Financial Loss
February 16, 2024
Tickers
CYBN
NEWS
Tags
Cannabis
Psychedelics
Opinion
From
Benzinga
Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment
February 01, 2023
Tickers
CYBN
DMT
Tags
Cannabis
Cybin
Psychedelics
From
Benzinga